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Allelic exclusion is a mechanism that permits expression of only one of the two
sets of parental Ig alleles (1-5). How this occurs is not known, but experiments in
transgenic mice suggest that it is mediated by the membrane-bound form of the 4
heavy chain (6). It is likely that exclusion operates by inhibitingV/DJ or D/J recom-
bination of the nonexpressed allele (4, 5). Nevertheless, most mature B cell lines
and many spleen B cells carry two completely rearranged heavy chain genes (5).
These rearranged genes might be accounted forifonly one were capable ofproducing
a functionalheavy chain, the other having rearranged aberrantly (7). Alternatively,
it is possible that the functional Ig product ofone allele suppresses a postrearrange-
ment step in the expression of the second. To test the latter hypothesis, we set out
to determine whether two functionally intact heavy chain genes could be expressed
simultaneously in primary B lymphocytes in vivo. For this purpose we created strains
of transgenic mice that carry either of two forms of a human P gene. One strain
carries a gene encoding only membrane-bound human p heavy chains (6). Another,
similar to that produced by Storb et al. (8), carries a human w gene that can only
direct the synthesis ofsecreted IgM heavy chains. We have examined the expression
of transgenic and endogenous heavy chains in both types ofmice and in their hybrid
progeny.
Materials and Methods
TransgenicMice.
￿
DNA used for pronuclear injection was from a human R gene whose mem-
brane exons were deleted by Sal I digestion (9). Sal I was also used to linearize the insert
and eliminate vector sequences (Fig. 1 A). Pronuclei of fertilizedone-cell mouse eggs derived
from FVB/N mice were injected and transferred to pseudopregnant females as previously
described (10). Two lines oftransgenic mice carrying the secreted gene were produced (TG. ST
and TG .SU).
DNA and RNA Isolation.
￿
DNA from mouse tails and RNA from tissues were prepared
as previously described (10). Poly(A)` RNA was selected by oligo(dT) chromatography (11).
DNA andRNA Analysis.
￿
DNA was denatured in 0.3 M NaOH, spotted onto nylon filters
(New England Nuclear, Boston, MA), and a Pvu II human R fourth constant region (pCH4)
probe (see Fig. 1) was used to identify transgenic mice. To distinguish between the w trans-
genes, DNA was digested with Pst I. RNA samples were electrophoresed in 1% agarose and
0.6% formaldehyde gels and transferred to nitrocellulose for hybridization assays. RNase
protection assays were performed as described by Melton et al . (12). Probes illustrated in
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FIGURE 1 . Expression of se-
creted Ig p and Ig p mRNA in
transgenic mice . (A)IgM trans-
gene with membrane exons
deleted by Sal I digestion . (B)
Human 1+ and a2-microglobu-
lin mRNA expression in spleens
of transgenic mice . mRNA was
assayed by RNase protection
using the probes diagrammed .
The sizes of protected fragments
given are in nucleotides (C)Hy-
bridization analysis of RNA
from TG .ST and wild-type
mouse spleen . The Ly-65 Bur-
kitt lymphoma cell line pro-
duces authentic human g and
was used as a control (20) . The
samples were either 2 pg of
poly(A)' or 20 pg of poly(A)-
RNA . (D) Immunoblots of
authentic human Ig p, trans-
genic and wild-type mouse
serum samples . L, leader exon ;
VDJ, variable region exon ; E,
enhancer ; Sw, switch ; Cl-4,
constant region exons ; pAA . ., polyadenylation signal ; Ml-2, membrane exons;WT, wild type ; TG .ST
and TG.SU, transgenic strains that carry the secreted Ig p gene ; TG.SA, transgenic strain that carries
the membrane-bound Ig p gene ; Ly-65, Ly-65 cell line ; A+, oligo(dT)-selected RNA; A-, RNA that
did not bind to oligo(dT) ; Hu Ig, purified human Ig p standard ;WT sr, wild-type mouse serum ; TG
sr, transgenic mouse serum ; hp-CH4, human p fourth constant region ; 02-Bal, 02-microglobulin probe;
Sd, splice donor; S, secreted ; M, membrane ; B, a2-microglobulin ; u, position of Igp 75 kD ; g, position
of Igy, 50 kD ; 1, position of light chains, 20 kD; Pvu, Pvu I ; Kpn, Kpn I .
Figs . 1 and 2 were cloned into pGEMT""-3 or 4 vectors (Promega Biotec, Madison, WI) so
that SP6 transcription was antisense in all cases (6) . The t"2-microglobulin Bal I probe was
produced by Bal-31 deletion of 28 nucleotides from the Tend of a previously described a2 -
microglobulin probe (6, 13) .
Immunoblots .
￿
Human u protein was concentrated from pooled transgenic mouse sera by
affinity chromatography on columnsof goat anti-humanIgM (CooperBiomedical, Inc., Mal-
vern, PA) coupled to cyanogen bromide-activated Sepharose4B (Pharmacia Fine Chemicals,
Piscataway, NJ) . The equivalent of 10 wg of immunoreactive material was electrophoresed
in 8% polyacrylamide, SDS gels and transferred to nitrocellulose (14). Biotin-labeled mono-
clonal anti-humanIgM (15), or biotin-labeled goat anti-human IgM(Southern Biotechnology
Associates, Inc., Birmingham, AL) and HRP-Avidin (Vector Laboratories, Inc., Burlingame,
CA) were used to detect human k protein . 10 wg of purified human IgM protein (Cappel
Laboratories, Malvern, PA) was used as a standard in all experiments .
Flow Cytometry.
￿
Single cell suspensions from spleens were stained with a monoclonal
anti-mouse IgM (16) directly labeled with fluorescein (Becton Dickinson&Co., Mountain
View, CA)- The labeled cells were analyzed or sorted by standard flow cytometry on a
Cytofluorograf IIS (Ortho Diagnostic Systems Inc., Westwood, MA).
Results and Discussion
SecretedHuman Ft mRNA and Protein are Produced in Transgenic Mice.
￿
Spleen cells from
transgenic mice that carry the gene that encodes secreted g (strains TG .ST and
TG.SU) express only the secreted form of human g mRNA as assayed in RNase
protection experiments (Fig . 1 B) . As shown by analysis of poly(A)' and poly(A) -NUSSENZWEIG ET AL . BRIEF DEFINITIVE REPORT
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FIGURE 2 .
￿
Expression of en-
dogenous mouse w and trans-
genic human ~L mRNA in
transgenic mice and their hybrid
progeny. (A) Mouse u and ß2 -
microglobulin mRNA expres-
sion in transgenic, hybrid, and
wild-type spleenRNA samples
were measured by RNase pro-
tection . RNase protection .
probes and the size of the frag-
ments expected from protection
in nucleotides are diagrammed .
Duplication of the sequence
ATAAAAA found at the 3' end
of the murine secreted
mRNA could result in a 23-
nucleotide loop that would pro-
duce the doublet observed . (B)
Human Ig ~i mRNA in spleen
cells ofTG .ST mice that had been selected for the presence or absence of cell surface mouse IgM .
(C) Human Igu and 02-microglobulin mRNA expression in transgenic, hybrid, and wild-type spleens .
RNAs were assayed by RNase protection in the same spleen RNA samples shown in A . Abbreviations
are the same as in Fig . I with the addition of: TG.ST/SA , Fl hybrid animals that carry both secreted
and membrane g transgenes ; Ig+, sorted TG.ST spleen cells that have mouse IgM on their surface ;
Ig-, sorted spleen cells that do not have IgM on their surface ; t, tRNA ; ß2-micro, ß2-microglobulin
probe ; mw-CI4, fourth constant region of mouse Ig p ; Sac, Sac I ; Pst, Pst I ; H, Hind III .
fractions of spleen RNA, transgenic mRNA is of the expected size (2.4 kb), and is
polyadenylated (Fig . 1 C) . In addition, this mRNA is induced by LPS in vitro, and
human IgM is present in transgenic mouse serum at a level of 10 pg/ml as radioim-
munoassayed with both polyclonal and monoclonal antibodies (not shown) . The im-
munoreactivity can be accounted for by a protein of the size ofhuman P in Western
blots (Fig . 1 D) .
The number ofmouse IgM-bearing splenic B cells is reduced in transgenic mice
carrying the gene for the membrane-bound form of human It (6) . By contrast, the
number ofmouse IgM+ splenic B cells was not significantly different in the secreted
It transgenics and wild types . Furthermore, the expression of other B cell, T cell,
and macrophage surface markers was also similar (not shown) . Thus, expression
of secreted human g does not seem to affect the number of T cells, macrophages,
or mouse IgM-bearing B cells in the spleen .
Secreted Human u Does Not Suppress Expression of Mouse IgM.
￿
To test the effect of
the secreted form ofhuman g . on the level of endogenous mouse u, we measured
endogenous u mRNA in spleen cells by RNase protection (Fig . 2 A) . ß2-microglob-
ulin was used as a control for the amount ofmRNA in the sample . Unlike the mem-
brane u transgene, the presence of the secreted form ofhuman g has no significant
effect on the level ofendogenousmouse IgM mRNA (Fig. 2A ; seeTG.SA vs. TG.ST
vs . WT) .
To confirm that the human secreted w chains are expressed in the same cells that
express mouse IgM, we purified mouse IgM+ B cells from the spleens of transgenic
mice using a cell sorter. RNA was extracted from the sorted cells that were >97%
pure on reanalysis (not shown) . In RNase protection assays, secreted human g
mRNA was detected in similar quantities in cells that were either positive or nega-197 2
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tive for cell surface mouse IgM (Fig. 2 B). Expression of human g in the mouse
IgM - pool is consistent with the presence of both pre-B cells and T cells in this
population. Both of these cell types would be expected to transcribe the human A
transgene (8, 17). However, expression of the secreted human 4 mRNA in mouse
IgM' B cells seems to violate allelic exclusion since two types of IgM molecules,
human and mouse, are being produced in the same cells. Production of more than
one type of IgM molecule in a B cell could account for the relatively low level of
human g in serum if there is preferential association between murine light and heavy
chains . Incomplete human IgM molecules or partial chimeras between human and
mouse proteins might either fail to be secreted or, once secreted, may be cleared
more rapidly from serum. Whether the transgenic animals are tolerant to human
IgM has yet to be determined.
The most likely explanation for our results is that the secreted 4 protein, unlike
the membrane-bound, is unable to signal allelic exclusion. However, the secreted
transgene differs from the membrane transgene in that the level of expression of the
former is relatively lower (10-30% ; Figs. 1 A and 2 C). In addition, the secreted
human g gene is missing the 3' nucleotide sequences that include and flank the two
small transmembrane and cytoplasmic exons. It is unlikely that the level of expres-
sion influences allelic exclusion since we have observed allelic exclusion in a trans-
genicline that produces only 5 % of the membrane mRNA found in TG.SA (TG.SD
[6]) (data not shown). A definitive experiment to examine the effects of the 3' se-
quences would require a transgene with a mutation that prevents translation of the
membrane exons.
Two Functional Ig Genes Can Be Coexpressed.
￿
While it is clear that allelic exclusion
operates by preventing the rearrangement of Ig genes (3-5, 18, 19), the possibility
that this control could operate at some further step in gene expression has not been
tested. The availability of independent strains of transgenic mice that produce two
different types of functional g chains, membrane-bound and secreted, allows us to
test this possibility in vivo. By crossing mice that carry the secreted transgene (TG.ST)
with mice that carry the membrane g transgene (TG.SA), we obtained mice that
carry both types of productively rearranged human g genes. Since both Ig trans-
genes are rearranged, expression of these two functional alleles can only be influenced
by events that operate following VDJ joining.
RNAs from spleens of five independent litters of F, animals were analyzed. When
both the membrane-bound and secreted g transgenes are present in a single hybrid
mouse, both genes are expressed at levels seen when each is present alone (Fig.
2 C [ TG .SA and TG .ST vs. TG.SA/ST]). At the same time, mouse g expression
is decreased in these mice, presumably as a consequence of the expression of the
membrane-bound human transgene (Fig. 2 A [TG .ST/SA]). Thus, the membrane
g transgene can exclude mouse g production, but has no effect on the expression
of a productively rearranged secreted human g gene.
Summary
Expression of the membrane-bound version of the human g chain in transgenic
mice results in the allelic exclusion of endogenous mouse Ig heavy chain genes (6).
The secreted version of the human Ig transgene has no such effect. F1 hybrid
animals that carry transgenes for both secreted and membrane-bound human gNUSSENZWEIG ET AL. BRIEF DEFINITIVE REPORT
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chains produce both forms of the human heavy chain while strongly suppressing
endogenous mouse K expression. The simultaneous expression of the two rearranged
transgenes in primary B cells suggests that allelic exclusion operates before the for-
mation of a second functionally rearranged heavy chain gene in vivo.
We thank H. C. Morse, III and K. L. Holmes for many helpful discussions.
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